Elligo Health Research®, a healthcare-enabling research organization, is launching their fully realized System of Accelerated Research (SOAR) model for decentralized (DCTs) and hybrid trial models with fully remote monitoring capabilities.
Solution for the Future of Research
Elligo Health Research®, a healthcare-enabling research
organization, is launching their fully realized System of Accelerated Research
(SOAR) model for decentralized (DCTs) and hybrid trial models with fully remote
monitoring capabilities.
Only Elligo has developed as a
continuum of technologies and data science capabilities; Elligo’s SOAR™ model expands patient access to
reach diverse patient populations that typically don’t have access to clinical
research as a care option. The solution drives efficiency by enabling direct
data from source to submission and full remote site access, empowering
patients, physicians, and sponsors to conduct more trials efficiently and
faster in traditional and decentralized models.
“We are extremely excited to launch
our tech-enabled solution created to keep the patient and the physician at the
heart of its design, while providing sponsors transparency,” said John Potthoff, Ph.D., CEO of Elligo. “Our
goal has always been to provide all patients with access to research as a
healthcare option, which is important now more than ever as we navigate the
future of clinical research.”
SOAR not only mitigates risk, but
adheres to regulations and improves data quality while decreasing resource
requirements and costs associated with clinical research. Paired with
technology-enabled services and expert personnel, this model accelerates
research without compromising quality and integrity. This provides a pathway to
either use traditional research sites, DCTs, or hybrid trials, seamlessly
moving between options without causing disruption for any stakeholders. This
modernizes clinical research for a new paradigm in a new age of clinical
research.
About Elligo Health Research®
Elligo Health Research, a
healthcare-enabling research organization, uses electronic health records and
the trusted patient and physician relationship to ensure all patients have
access to clinical research as a care option. Powered by our Goes Direct® approach and novel IntElligo® Research Stack clinical
technology, our team provides access to the best healthcare experts, patients,
and research technologies. We engage physicians and patients who otherwise
would not participate in clinical research and accelerate the development of
new pharmaceutical, biotechnology, and medical device and diagnostic products.
Learn more at elligodirect.com.